GLP-1 Receptor Agonists: Beyond Their Pancreatic Effects

Glucagon like peptide-1 (GLP-1) is an incretin secretory molecule. GLP-1 receptor agonists (GLP-1RAs) are widely used in the treatment of type 2 diabetes (T2DM) due to their attributes such as body weight loss, protection of islet β cells, promotion of islet β cell proliferation and minimal side eff...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Xin, Wang, Minghe, Wen, Zhitong, Lu, Zhihong, Cui, Lijuan, Fu, Chao, Xue, Huan, Liu, Yunfeng, Zhang, Yi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8419463/
https://www.ncbi.nlm.nih.gov/pubmed/34497589
http://dx.doi.org/10.3389/fendo.2021.721135

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8419463/
https://www.ncbi.nlm.nih.gov/pubmed/34497589
http://dx.doi.org/10.3389/fendo.2021.721135

Ejemplares similares